Referenties:
Gómez Candela C, Bermejo López LM, Loria Kohen V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health. Nutritional recommendations. Nutr Hosp 2011; 26(2): 323-329.
Heinze VM, Actis AB. Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review. Int J Food Sci Nutr 2012; 63(1): 66-78.
Le Quotidien du Médecin. Réduire le risque résiduel. Edition spéciale Congrès. Sessions scientifiques de l’American Heart Association (New Orleans, 2008). Artikel
Martín de Santa Olalla L, Sánchez Muniz FJ, Vaquero MP. N-3 fatty acids in glucose metabolism and insulin sensitivity. Nutr Hosp 2009; 24(2): 113-127.
Pagourelias ED, Gossios TD, Tziomalos K et al. Residual cardiac risk reduction beyond lipid lowering. Hellenic J Cardiol 2011; 52: 197-203.
Sangmi K et al. Intake of polyunsaturated fatty acids and distal large bowel cancer risk in Whites and African Americans. Am. J. Epidemiol 2010; 171(9): 969-979.
Sun H, Hu Y, Gu Z, Owens RT et al. Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Carcinogenesis 2011; 32(10):1518-24.
van der Meij BS, van Bokhorst-de van der Schueren MA, Langius JA, et al. n-3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral supplementation. Am J Clin Nutr. 2011; 94(5): 1248-65.
West NJ, Clark SK, Phillips RKS et al. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 2010; 59: 918-925.